These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22066734)
21. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. Ozturk B; Kuscu F; Tutuncu E; Sencan I; Gurbuz Y; Tuzun H J Clin Virol; 2010 Feb; 47(2):115-9. PubMed ID: 20005156 [TBL] [Abstract][Full Text] [Related]
22. Cytokine levels in Crimean-Congo hemorrhagic fever. Papa A; Bino S; Velo E; Harxhi A; Kota M; Antoniadis A J Clin Virol; 2006 Aug; 36(4):272-6. PubMed ID: 16765637 [TBL] [Abstract][Full Text] [Related]
23. The frequency of self-reported allergic diseases in patients with crimean-congo haemorrhagic fever. Abadoglu O; Engin A Allergol Immunopathol (Madr); 2009; 37(5):234-8. PubMed ID: 19775796 [TBL] [Abstract][Full Text] [Related]
24. Crimean-Congo hemorrhagic fever disease due to tick bite with very long incubation periods. Kaya A; Engin A; Güven AS; Içağasıoğlu FD; Cevit O; Elaldı N; Gültürk A Int J Infect Dis; 2011 Jul; 15(7):e449-52. PubMed ID: 21511509 [TBL] [Abstract][Full Text] [Related]
25. Parotitis associated with Crimean Congo hemorrhagic fever virus. Kaya S; Yilmaz G; Ertunç B; Koksal I J Clin Virol; 2012 Feb; 53(2):159-61. PubMed ID: 22079303 [TBL] [Abstract][Full Text] [Related]
26. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever. Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857 [TBL] [Abstract][Full Text] [Related]
28. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402 [TBL] [Abstract][Full Text] [Related]
29. Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses? Ozsurekci Y; Arasli M; Karadag Oncel E; Caglayik DY; Kaya A; Icagasioglu FD; Engin A; Korukluoglu G; Elaldi N; Ceyhan M J Med Virol; 2013 Nov; 85(11):1955-9. PubMed ID: 23893846 [TBL] [Abstract][Full Text] [Related]
30. Recombinant nucleoprotein-based serological diagnosis of Crimean-Congo hemorrhagic fever virus infections. Saijo M; Tang Q; Shimayi B; Han L; Zhang Y; Asiguma M; Tianshu D; Maeda A; Kurane I; Morikawa S J Med Virol; 2005 Feb; 75(2):295-9. PubMed ID: 15602720 [TBL] [Abstract][Full Text] [Related]
31. Investigation of NF-κB1 and NF-κBIA gene polymorphism in non-small cell lung cancer. Oltulu YM; Coskunpinar E; Ozkan G; Aynaci E; Yildiz P; Isbir T; Yaylim I Biomed Res Int; 2014; 2014():530381. PubMed ID: 24707489 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. Bakir M; Bakir S; Sari I; Celik VK; Gozel MG; Engin A J Med Virol; 2013 Oct; 85(10):1794-801. PubMed ID: 23868816 [TBL] [Abstract][Full Text] [Related]
33. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Cevik MA; Erbay A; Bodur H; Eren SS; Akinci E; Sener K; Ongürü P; Kubar A Clin Infect Dis; 2007 Oct; 45(7):e96-100. PubMed ID: 17806044 [TBL] [Abstract][Full Text] [Related]
34. [Methods for the Crimean-Congo hemorrhage fever diagnosis]. Seregin SV; Petrov VS; Grishaev MP Mol Gen Mikrobiol Virusol; 2013; (4):26-31. PubMed ID: 24645275 [TBL] [Abstract][Full Text] [Related]
35. Molecular epidemiology of Crimean-Congo hemorrhagic fever virus in Turkey: occurrence of local topotype. Ozkaya E; Dincer E; Carhan A; Uyar Y; Ertek M; Whitehouse CA; Ozkul A Virus Res; 2010 Apr; 149(1):64-70. PubMed ID: 20079776 [TBL] [Abstract][Full Text] [Related]
36. [Two Crimean-Congo hemorrhagic fever cases without history of tick contact from Ankara region]. Kaya Kiliç E; Yilmaz U; Cesur S; Koçak Tufan Z; Kurtoğlu Y; Bulut C; Kinikli S; Irmak H; Demiröz AP Mikrobiyol Bul; 2009 Oct; 43(4):677-81. PubMed ID: 20084924 [TBL] [Abstract][Full Text] [Related]
37. [Crimean-Congo hemorrhagic fever: basics for general practitioners]. Flusin O; Iseni F; Rodrigues R; Paranhos-Baccalà G; Crance JM; Marianneau P; Bouloy M; Peyrefitte CN Med Trop (Mars); 2010 Dec; 70(5-6):429-38. PubMed ID: 21520641 [TBL] [Abstract][Full Text] [Related]
38. Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever. Akinci E; Yilmaz M; Bodur H; Ongürü P; Bayazit FN; Erbay A; Ozet G Int J Infect Dis; 2009 Sep; 13(5):560-3. PubMed ID: 19112036 [TBL] [Abstract][Full Text] [Related]
39. The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever. Menteşe A; Yilmaz G; Sümer A; Arslan M; Karahan SC; Köksal I Int J Infect Dis; 2013 Nov; 17(11):e1042-5. PubMed ID: 23632301 [TBL] [Abstract][Full Text] [Related]
40. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey]. Uyar Y; Carhan A; Albayrak N; Altaş AB Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]